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Abstract.  Caveolae are a  membrane specialization 
used to internalize molecules by potocytosis. Caveolin, 
an integral membrane protein, is associated with the 
striated coat present on the cytoplasmic surface of the 
caveolae membrane. We now report that oxidation of 
caveolar cholesterol with cholesterol oxidase rapidly 
displaces the caveolin from the plasma membrane to 
intracellular vesicles that colocalize with Golgi appara- 
tus markers.  After the enzyme is removed from the 
medium, caveolin returns to caveolae. When untreated 
cells are gently homogenized, caveolin on the plasma 
membrane is accessible to both anti-caveolin IgG and 
trypsin. After cholesterol oxidase treatment, however, 
Golgi-associated caveolin is inaccessible to both of 
these molecules. Brefeldin A, which inhibits ER to 
Golgi trafficking, blocks the appearance of caveolin in 
the Golgi apparatus but does not prevent caveolin from 
leaving the plasma membrane.  Indirect immunogold 
localization experiments show that in the presence of 
cholesterol oxidase caveolin leaves the plasma mem- 
brane and becomes associated with endoplasmic retic- 
ulum and Golgi compartments. Surprisingly, the loss 
of caveolin from the plasma membrane does not affect 
the number or morphology of the caveolae. 
C 
AVEOLAE are  a  membrane specialization found on 
the surface of many different cells (23,  36).  There 
is considerable evidence that they are an endocytic 
organelle that internalizes substances by forming plasma- 
lemmal vesicles (24).  In some cases these vesicles transport 
molecules across the cell (32) while at other times they de- 
liver low molecular weight molecules and ions to the cyto- 
plasm by a process called potocytosis (1). The cytoplasmic 
surface of each caveola is decorated with a  characteristic 
coat material that appears to be composed of integral mem- 
brane components (28).  One of the proteins associated with 
this coat is caveolin (28).  The caveolae coat may play a role 
in controlling membrane invagination. 
Potocytosis was discovered by studying receptor-coupled 
transport of folate in MA104 cells (15). At physiological con- 
centrations of 5-methyltetrahydrofolate,  the efficient  delivery 
of the vitamin to the cytoplasm of cells is dependent on a 
high affinity receptor that is anchored to the membrane by 
glycosylphosphatidylinositol (GPI) 1. The GPI-anchor causes 
the receptor to cluster in caveolae (30) where it becomes se- 
questered from the extracellular space each time a caveolae 
closes. Sequestered folate rapidly dissociates from the re- 
ceptor and crosses the membrane by an anion carrier (16). 
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Caveolae then open and another round of  potocytosis begins. 
Recently we showed (34) that activators of protein kinase C 
(PKC) inhibit potocytosis by preventing the invagination of 
caveolae. 
Caveolin was  originally identified as  a  22-kD  tyrosine 
phosphoprotein in chick embryo fibroblasts infected with the 
Rous sarcoma virus (11). Immunogold cytochemistry showed 
that over 90 % of the caveolin in the plasma membrane is as- 
sociated with caveolae and that small amounts of caveolin are 
also found in the Golgi apparatus (28). Independently, Kurz- 
chalia et al. (17) showed that a protein of the same molecular 
weight as caveolin (designated VIP21) is prominent in Golgi- 
derived vesicles destined for the apical cell surface. Cloning 
of the cDNA, first for VIP21 (17) and then for caveolin (10), 
revealed that they are the same protein. The sequence pre- 
dicts that it is an  integral membrane protein  synthesized 
without a leader peptide. The exact orientation of the protein 
in the plasma membrane is still not clear.  Some evidence 
suggests that the protein forms a hairpin loop in the mem- 
brane such that both ends are in the cytoplasm (9). Other evi- 
dence (21) favors the view that it is a type II transmembrane 
protein. 
The function of caveolin is not known. The association of 
this protein with the caveolar coat suggested that it might 
have a  structural role in maintaining the shape of the or- 
ganelle (28).  In polarized epithelial cells, caveolin first as- 
sociates with clusters of GPI-anchored membrane proteins 
in the Golgi apparatus (6, 21) before moving to the cell sur- 
face in transport vesicles (17). Therefore, caveolin may target 
GPI-anchored proteins and associated glycolipids to the api- 
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that plasmalemmal vesicles move from the cell surface to the 
Golgi apparatus as part of an internalization cycle. 
Both the structure (28) and the function (7) of caveolae are 
absolutely dependent on membrane cholesterol. Exposure of 
membranes to sterol-binding drugs such as filipin cause the 
caveolar coat to disassemble,  invaginated caveolae to be- 
come flat, and the GPI-anchored proteins to uncluster (28). 
Likewise, cells that are depleted of membrane cholesterol 
have unclustered GPI-anchored proteins, a reduced number 
of visible caveolae and potocytosis is impaired (7). These 
results are in agreement with the observation that caveolae 
have a much higher concentration of cholesterol than the sur- 
rounding plasma membrane (33). 
Oxidation of cholesterol has been implicated as a risk fac- 
tor in the development of atherosclerosis (14,  25). The es- 
sential role of cholesterol in caveola function suggests that 
it may be a plasma membrane domain that is especially sen- 
sitive to oxidative damage. To investigate this possibility, we 
used cholesterol oxidase to enzymatically oxidize fibroblast 
membrane cholesterol in situ.  Surprisingly, this treatment 
caused caveolin to migrate to the Golgi region of the cell 
without there being a change in the number of caveolae. Cav- 
eolin recycles back to the plasma membrane after cholesterol 
oxidase is removed from the media and the level of oxidized 
cholesterol in the membrane declines. 
Materials and Methods 
Materials 
Dulbecco's modified Eagle's medium, glutamine, trypsin-EDTA, and peni- 
cillin/streptomycin  were from Gibco Laboratories (Grand Island, NY). Fe- 
tal calf serum was from Hazleton Research Products, Inc. (Lenexa, KS). 
The analytical silica gel thin-layer chromatography plates and the following 
solvents were from J. T. Baker, Inc. (Philllpsburg, NJ): heptane, petroleum 
ether, ethyl ether, acetic acid, and 2-propanoL  [3H]acetate was obtained 
from DuPont (Wilmington, DE) with a  specific activity of approximately 
4.13 Ci/mmol. Trans-[35S]-label  was from ICN (Costa Mesa, CA). Cho- 
lesterol oxidase (Nocardia erythropolis), cholesterol and cholestenone  were 
from Boehrinser Mannheim Biochemicals (Indianapolis, IN). The sulfuric- 
dichromate spray was from Supelco Inc. (Bellefonte, PA). Protein A-Seph- 
arose (CL-4B) was from Pharmacla (Alameda, CA). Antibodies were ob- 
tained from the following sources: anti-caveolln IgG (mAb 2234) was a gift 
from Dr. John Glenney (Glentech, Inc., Lexington, ICO; rabbit anti-BiP 
IgG was from David Bole (University of Michigan, Ann Arbor, MI) (4); 
rabbit anti-galactosyltransferase IgG was from E.  G.  Berger (Physiolo- 
gisches Institute Universitat Zurich, Switzerland) (3); goat anti-mouse IgG 
conjugated to peroxidase was from Organon Tekuika Corp (West Chester, 
PA); goat anti-rabbit IgG conjugated to gold (10 rim) was from Biocell (Ted 
Pella, Redding, CA); mouse anti-dinitrophenol IgG was from Oxford Bio- 
medical (Oxford, MI); goat anti-mouse IgG conjugated to gold (10 nm) was 
from Energy Beam Sciences (A_gawam, MA). All other reagents were from 
Sigma Chem. Co. (St. Louis, MO). 
Me~o~ 
Cell Culture. Cultured fibroblasts were derived from a skin biopsy obtained 
from a normal patient. Cells were grown in a monolayer and set up accord- 
ing to a standard format (12).  On day zero, 2.5  x  105 cells were seeded 
into 100-ram Petri dishes with 3 ml of Dulbecco's modified Eagle's medium 
supplemented with penicillin, streptomycin, 10% (vol/vol) human lipopro- 
rein deficient serum. Cells were fed with fresh medium on day 3 and day 
5.  Cells were labeled with 75 #Ci of 3H-acetate on day six and used on 
day 7. 
Thin-layer  Chromatography.  The thin-layer chromatography experi- 
ments were carried out as previously described (22). Three confluent 100- 
mm dishes of fibroblasts were used for each sample. The labeled cells were 
washed extensively in PBS and then placed in 3 ml of buffer (DMEM, 20 
mM Hepes, pH 7.4) before the indicated treatments. The caveolae then were 
isolated on sucrose gradients (see below). Each gradient fraction was ad- 
justed to 1 ml final volume and treated with 30% tanrodeoxycbolate, 2 ml 
Dole reagent (2-propanol, 78%:  beptane, 20%:  water, 2%), and  I rni of 
heptane. The samples were vortexed and spun in a table top centrifuge for 
10 min (3000 g). The heptane phase (upper) contained lipids and was used 
for thin-layer chromatography. The aqueous phase (bottom) contained pro- 
teins and was used for immunoblots. The heptane phase was dried under 
N2  and  suspended in  50  t~l  of the  solvent system (80:20:1;  petroleum 
ether/ethyl ether/acetic acid). Pure cholesterol and pure cholestenone were 
dissolved in the solvent system and used as standards (5/tg/spot). The lipids 
were spotted onto a silica gel G plate and developed in the solvent system. 
Lipids were visualized by charring with sulfuric acid-dichromate and heat- 
ing at  180°C  for  10 min.  Unlabeled cholesterol and cholestenone were 
added to each fraction to facilitate visualization. The appropriate spots were 
scraped  and  the  amount  of radiation  quantified  by  liquid  scintillation 
counting. 
Caveolae Isolation. Caveolae were isolated as described by Sargiacomo 
and colleagues (31). Three confluent, 100-ram dishes of human fibroblasts 
(10 nag protein) were used for each sample. All of the solutions contained 
a cocktail of protease inhibitors consisting of: ieupeptin (10/~M),  benzami- 
dine (0.5 raM), soybean trypsin inhibitor (10/~g/ml),  pepstatin A (1/~g/ml), 
and PMSF (0.2 mg/ml). Each dish was washed briefly with MBS (25 mM 
MES, pH 6.5; NaCI, 0.15 M) at room temperature. MBS plus 0.02 % ED'I'A 
was added to each dish for 10 min on ice. The cells were pelleted in a table 
top centrifuge for 5 min, 1400 g, 4 °C. Cells were suspended with a pipette 
tip in 1.0 ml MBS containing 1% Triton X-100. The samples were incubated 
on ice for 20 min and then dounced 20x in a I ml tight dounce. The samples 
were diluted with an equal volume of 85 % sucrose. The mixed material was 
placed at the bottom of a  centrifuge tube (TH641;  Sorvaii Instruments, 
Newton, CT) and a 10-30% linear sucrose gradient was layered on top. The 
samples were centrifuged at 143,200 g for 4 h at 4°C. After centrifugation 
the gradient was fractionated in 0.65-ml fractions before analysis. 
Triton Solubility.  Three  100-ram dishes of confluent fibroblasts were 
used for each sample. Cells were grown 22 h in methionine-free media that 
contained 300  ~tCi of [35S]methionine  (sp act  1132 Ci/mmol),  washed 
three times with DMEM and then incubated for 5 h in the presence of 50 
ftg/ml of cycloheximide. The cells were washed extensively in PBS and sub- 
jected to the indicated treatments, all in the presence of cyclobeximide. 
Cells were released from the dish by incubating in MBS plus 0.02%  EDTA 
for 10 rain on ice. The cells were collected by centrifuging for 5 min, 1400 g 
at 4°C. The pellets were suspended in 1.0 ml of MBS plus 1% Triton X-100 
and incubated on ice for 20 rain. The samples were dounced 20 times and 
spun in a mierofuge for 5 rain,  16000 g at 4°C. The supernatant fraction 
was collected and designated as the Triton-soluble fraction. The pellet was 
suspended in MBS plus 1% Triton and designated the Triton-insoluble frac- 
tion. Caveolin was immunoprecipitated from each of these fractions as de- 
scribed below. 
Immunoprecipitation  of Caveolin.  Protein A-scpbarose beads were 
first blocked by incubating them for 4 h at 4oc with human fibroblast cell 
lysate (200/tg/ml) plus 30 mg/ml of BSA in MBS buffer that contained 1% 
Triton X-100  and 60 mM octylgiucoside (MBSD buffer). Blocked beads 
were used to pre-clear the Triton X-100 soluble and insoluble fractions that 
had been suspended in MBSD. Pre-cleared fractious were then incubated 
for 19 h at 4°C with a  1:400 dilution of mAb anti-caveolin before adding 
blocked, Protein A-scpharose beads and incubating an additional 2 h at 
4°C. Beads were removed by centrifugation, dissolved  in sample  buffer (18), 
and proteins separated by electrophoresis. The autoradiograph was exposed 
for 48 h. 
Protease Protection. Two 100-mm dishes of confluent fibroblasts were 
used for each sample. Cells that had been preincubated for 5 h in the pres- 
ence of  50/~g/ml of  cycloheximide  were washed extensively in PBS and sub- 
jected to the indicated treatments, all in the presence of cycloheximide. At 
the end of the treatments, cells were removed from the dish with Trypsin- 
EDTA. Cells were collected by centrifugation at 1400 g for 5 rain and then 
washed in 5 ml of lysis buffer (1  mM NaHCO3;  1 ram MgC12; 10 mM 
KC1; 5 mM Hepes, pH 7.5; 0.3 M sucrose). Cells were pelleted at 1400 g 
for 5 rain and then suspended in 0.5 ml of ice cold lysis buffer.  Cells were 
broken by douncing 20 times with a 1 ml type A dounce homogenizer. The 
appropriate samples were incubated with 300/~g of trypsin for 30 win on 
ice. Soybean trypsin inhibitor (300 ~g) was then added and the sample was 
centrifuged for 1 rain at 600 g to remove unbroken cells. The remaining 
suspension was centrifuged at 100,000 g for 60 min at 4°C. The pellet was 
suspended in lysis buffer and analyzed by immunoblotting. 
Electrophoresis and Immunoblots.  Protein concentrations were deter- 
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Labs, Richmond, CA). Proteins were concentrated by trichloroacetic acid 
precipitation. Pellets were dissolved in sample buffer and heated at 95°C 
for 3 min before being loaded onto gels. Proteins were separated in a 12.5 % 
SDS-polyacrylamide gel using the method of Laemmli (18). Separated pro- 
teins were then transferred to nylon by the method of Towbin (35). The ny- 
lon was blocked in TBST  (20 mM Tris,  pH 7.6;  137  mM NaC1;  0.5% 
Tween-20) plus 3 % dry milk for 1 h at room temperature. Anti-caveolin 
mAb 2234 diluted 1/500 in TBST +  1% dry milk was added for 1 h at room 
temperature. After incubating with the primary antibody, the nylon was 
washed four times, 10 win each in TBST plus 1% dry milk. The secondary 
antibody (goat anti-mouse conjugated to horseradish peroxidase) was di- 
luted 1/30,000 and added for 1 h at room temperature. The nylon was then 
washed and bands visualized using enhanced chemiluminescence. 
Indirect Immunofluorescence.  Cells grown on glass coverslips were 
washed three times with PBS. After the indicated treatment, the cells were 
washed in PBS and fixed for 45 min at room temperature either with 3 % 
(wt/vol) paraformaldehyde in PBS or with a fixative that contained 3.7% 
paraformaldehyde, 70  mM Lysine-HCl, and  10  mM NaIO4  in 20 mM 
MES buffered saline (pH 7.0). After fixation, the cells were rinsed with PBS 
and incubated in 100 mM NI-I4CI-PBS for 10 min at room temperature. 
Cells were permeabilized with 0.1%  Triton X-100 for 7  min on ice and 
washed extensively in PBS. Cells were then incubated sequentially with 
PBS plus 0.5% BSA for 1 h at room temperature, anti-caveolin mAb 2234 
diluted 1/350 in PBS plus 0.2% BSA for 1 h at room temperature and finally 
with 20/xg/ml F1TC-goat  anti-mouse IgG plus 0.2% BSA for 1 h at room 
temperature. Cells were washed three times with PBS after each incubation. 
To colocalize caveolin and galaetosyltransferase, the primary antibody incu- 
bation contained a mixture of mAb 2234 and polyclonal anti-galactosyl- 
transferase (1:350). The secondary antibody incubation contained a mixture 
of RITC-goat anti-mouse IgG and FITC-goat anti-rabbit IgG. The concen- 
tration of the individual antibodies in the mixtures was the same as when 
they were used alone. Cells were then washed briefly in distilled water and 
mounted in a 2.5% solution of 1,4-diazabicyclo-(2.2.2)oetane. Cells were 
photographed using a Zeiss Photomicroscope HI. 
Iramunoelectron  Microscopy.  Cells  were  washed quickly  with  EM 
buffer (100 mM sodium phosphate, pH 7.6, 3 mM KC1, 3 mM MgCi2) and 
then fixed with 3 % (wt/vol) paraformaldehyde plus 3 mM trinitrophenol in 
EM buffer for 45 rain at room temperature. The cells were rinsed with EM 
buffer for 10 rain and then incubated for 20 min with 100 mM NI-I4CI in 
EM buffer at 4°C. Cells were rinsed with EM buffer for 10 min and then 
incubated with EM buffer that contained 0.15% bovine serum albumin and 
0.01% saponln for 30 min at 4°C. Samples were incubated either with anti- 
caveolin mAb 2234 (1/100) or control mAb 2001  (20 t~g/ml), rinsed, and 
then incubated with 20 ~tg/ml goat anti-mouse IgG conjugated to dinitro- 
phenol (DNP); all with EM buffer plus 0.15% BSA and 0.01% saponin. All 
antibody incubations were 1 h at 4°C. Cells were fixed with 2% glutaralde- 
hyde in EM buffer and incubated with 100 mM NI-IaCI in EM buffer before 
post-fixation with 1% OsO4 containing 1.5 % potassium ferrieyanide in 100 
mM sodium phosphate (pH 7.6). Samples were then dehydrated, embedded 
in Eponate, sectioned and processed to localize DNP groups by immuno- 
gold labeling as previously described (26). Immunogold quantification was 
carried out using a  modification of a previously described method (30). 
Briefly, electron microscopic negatives were obtained by randomly photo- 
graphing 60 regions from 40 different cells in each experimental treatment. 
The negatives were enlarged using a hand held magnifier and the surface 
length of the cell, the number of caveolae and the number of gold particles 
were measured directly. 
Results 
Cholesterol oxidase converts plasma membrane cholesterol 
to cholestenone without penetrating the lipid bilayer and en- 
tering the cell (19).  To determine how much of the surface 
cholesterol in a living human fibroblast was accessible to the 
enzyme, we first metabolically labeled the cholesterol with 
tritium by growing the cells for 16 h in the presence of 36 
/zM  [3H]acetate  (4.13  Ci/mmol).  We  then  incubated  the 
cells in the presence or absence of 0.5 U/ml cholesterol oxi- 
dase for 1 h at 37°C. The radiolabeled lipids were extracted 
from the cell with organic solvents, separated by TLC, and 
measured with a liquid scintillation counter. Cholesterol oxi- 
dase reproducibly converted 5-7% of the total cellular cho- 
lesterol to cholestenone. 1-2 h after removal of the enzyme 
from the culture medium, all of the radiolabeled choleste- 
none disappeared from the cell. 
Caveolae are easily isolated from cultured cells because 
they are insoluble in Triton X-100 and, as a consequence, can 
be separated from other membranes by flotation on a sucrose 
gradient (31). We used this procedure to measure the amount 
of  caveolin,  [3H]-cholesterol  and  [3H]-cholestenone  that 
was in caveolae before and after exposure of the cells to cho- 
lesterol oxidase. Untreated ceils that had been homogenized 
in detergent were loaded on the bottom of a  10 to 30% su- 
crose gradient and centrifuged at 143,200 g for 4 h (Fig.  1 
A).  Immunoblots (Fig.  1 A, Immunoblot)  showed that the 
majority of the caveolin was in fraction 10,  which is well 
separated from the starting material in fraction 14.  Frac- 
tion  10  contained  only  6%  of the  total  [3H]-cholesterol 
(Fig. 1 A, 1), with the remainder in fractions 12-14.  [3H]- 
cholestenone was not present in any of the fractions (Fig.  1 
A, <3). A dramatically different profile was seen after cho- 
lesterol oxidase treatment (Fig.  1 B).  Virtually all of the 
[3H]-cholesterol in  fraction  10  (Fig.  1  B,  l)  had  been 
replaced by [3H]-cholestenone (Fig.  1 B, o). This was the 
exclusive location  of oxidized cholesterol in  these  cells. 
More remarkably, caveolin was no longer in fraction 10 (Fig. 
1 B, Immunoblot)  but remained in the starting material (Fig. 
1 B, Fraction 14). The quantitative conversion of the choles- 
terol in fraction 10 to cholestenone suggests that all of the 
oxidase-sensitive cholesterol in a living fibroblast is in the 
caveolae. 
The caveolin may have remained in the starting material 
after cholesterol oxidase treatment because oxidized sterols 
render the protein soluble in Triton X-100 (Fig. 2). To test 
this idea, we first grew cells overnight in [35S]methionine to 
metabolically label caveolin. Protein synthesis was stopped 
by adding cycloheximide to the media for 5 h and the cells 
were incubated in the presence or absence of 0.5 U/ml cho- 
lesterol oxidase for 1 h at 37°C. We then homogenized the 
cells in Triton X-100,  separated the soluble (Fig. 2,  Triton 
Soluble) and insoluble (Fig. 2, Triton Insoluble)  material by 
centrifugation, and immunoprecipitated each fraction with 
mAb anti-caveolin IgG. All of the caveolin in untreated cells 
was in the insoluble fraction (Fig. 2, NT). After 60 min of 
cholesterol oxidase treatment, however, all of the caveolin 
was in the soluble fraction (Fig. 2, CO). Removal of the cho- 
lesterol oxidase from the culture medium caused a progres- 
sive  return of caveolin to the  insoluble  fraction (Fig.  2, 
chase).  90 min after removal of oxidase, all of the caveolin 
was Triton insoluble (Fig. 2, 90 min). Separate experiments 
showed that cholestenone disappeared from the cells within 
60  min  after  cholesterol oxidase  was  removed from the 
medium (data not shown). We observed a quantitative (Fig. 
2, compare band intensities) return of the Triton soluble cav- 
colin to the insoluble fraction after cholesterol oxidase was 
removed from the media even though protein synthesis was 
blocked during this time. 
Caveolin Reversibly Moves to the Golgi Apparatus 
These results suggested that cholesterol oxidase caused the 
caveolin to leave the caveolae without changing the physical 
integrity of the caveolar membrane. Indirect immunofluores- 
Smart et al.  Caveolin Traffic to Golgi Region  1187 Figure 1.  Distribution of cho- 
lesterol,  cholestenone  and 
caveolin in caveolae isolated 
from  either untreated  (A) or 
cholesterol  oxidase-treated 
(B)  ceils.  Human  fibroblasts 
were incubated for 1 h at 37°C 
in  the  presence  of  either 
medium alone (A) or medium 
that  contained  0.5  U/ml  of 
cholesterol oxidase (B). Both 
sets of cells were solubilized 
in 1% Triton X-100 and caveo- 
lae isolated by flotation in a 
sucrose  gradient.  Fourteen 
fractions  from  the  gradient 
were  analyzed  for  the  pres- 
ence  of  caveolin  (Immuno- 
blot),  cholesterol  (I)  and 
cholestenone (o) as described 
in  Materials  and  Methods. 
The arrow indicates the caveo- 
lae fraction. 
cence (Fig. 3, A,  C, and E) and immunogold electron mi- 
croscopy (Fig. 3, B, D, and F) confirmed this interpretation. 
The anti-caveolin IgG immunofluorescence staining pattern 
of untreated cells is shown in Fig. 3 A. The caveolin was pri- 
marily on the surface, concentrated in patches along the edge 
and over the body of the cell (Fig. 3 A). Immunogold labeling 
showed that nearly all of the caveolin was associated with in- 
Figure 2. Effects of cholesterol oxidase on the Triton X-100 solubil- 
ity of caveolin. Human fibroblasts were incubated in the presence 
of trans-[35S]-label  overnight,  washed  and  further  incubated  in 
cold media that contained 50 #g/ml of cycloheximide for 5 h. They 
were then incubated for 1 h in the presence of either medium alone 
(ART) or medium that contained 0.5  U/ml of cholesterol oxidase 
(CO and chase). One set of cholesterol oxidase treated cells (chase) 
was incubated further for the indicated time in medium that did not 
contain any enzyme. Cycloheximide  was present during all incuba- 
tions. After each treatment, cells were removed from the dish with 
1%  Triton X-IO0 and the soluble (Triton soluble) and insoluble 
(Triton insoluble) fractions separated by centrifugation. Caveolin 
was immunoprecipitated from each fraction as described in Ma- 
terials and Methods. 
The Journal of Cell Biology,  Volume 127, 1994  1188 Figure 3. Immunoltuorescence (A, C, and E) and immunogold (B, D, and F) localization of caveolin in untreated (A and B) and cholesterol 
oxidase-treated (C-F) cells. Human fibroblasts were incubated fo 1 h at 37°C in either medium alone (A and B) or medium that contained 
0.5 U/ml of cholesterol oxidase (C-F). One set of cholesterol oxidase-treated cells (E and F) was incubated an additional 1 h in medium 
that did not contain any enzyme. At the end of the incubations, cells were processed to localize caveolin using either immunofluorescence 
(A, C, and E) or immunogold (B, D, and F) immunocytochemistry.  Bar, (a, c, and e) 5.7 #m; (b, d, and f) 0.4 #m. 
vaginated caveolae at the cell surface (Fig. 3 B, bottom) and 
that very little was present in the Golgi apparatus (Fig. 3 B, 
top). A  1-h treatment with cholesterol oxidase at 37°C dra- 
matically changed this distribution.  The caveolin now ap- 
peared in numerous vesicles that were concentrated near the 
nucleus of the cell (Fig. 3  C).  Examination of treated cells 
with the electron microscope (Fig.  3 D) showed that in re- 
sponse to oxidation of cholesterol, cells accumulated numer- 
ous vesicles that were associated with the Golgi apparatus. 
The lumen of many of these vesicles was heavily labeled with 
anti-caveolin IgG-gold (Fig. 3 D, top [*]). There also was a 
dramatic reduction in the amount of gold in caveolae (Fig. 
3 D, bottom) although caveolar morphology was unchanged. 
Quantification of the gold particles (Table I A) showed that 
cholesterol oxidase caused a ,,o60%  decrease in the number 
of gold particles associated with caveolae. By contrast, there 
was only a  10% decline in the number of caveolae. Most of 
the  caveolin returned  to  the  cell  surface (Fig.  3  E)  after 
removal of cholesterol oxidase for 1 h at 37°C. The Golgi re- 
gion returned to a more normal appearance, although some 
Smart et al. Caveolin Tra~c to Golgi Region  1189 Table L Distribution of Caveolin After Cholesterol Oxidase Treatment 
A. Cholesterol Oxidase at 37"C 
% Labeled  Total  Gold/labeled 
Treatment  caveolae  Total gold  caveolae  caveola 
Caveolae/ 
I0 t~m 
Control  47  1519  635  4.4 
Cholesterol 
oxidase  29  632  632  3.6 
B. Cholesterol  Oxidase at 18"C then Warmed ( ~ ) to 370C 
% Labeled  Total  Gold/labeled 
Treatment  caveolae  Total gold  caveolae  caveola 
1.65 
1.47 
Control @ 18°C  65  5710  473  4.15 
CO @ 18°C  41  4489  421  4.17 
co @ 18"c 
;  48  3394  560  3.92 
37°c 30 min 
CO @ 18"C 
4  31  1927  525  3.22 
37°C 90 min 
Human fibroblasts were subjected to the same conditions as described in the legend to Fig. 3 (for A) or Fig. 7 (for B) and then processed for quantification of 
anti-caveolin mAb gold as described. 
of the trans-most cisternae appeared to be dilated (Fig. 3 F, 
top [*]). Very little immunogold was present in these cister- 
nae.  The quantity of caveolae-associated gold returned to 
normal levels (Fig. 3 F, bottom). The return of caveolin to 
caveolae paralleled the decline in membrane cholestenone. 
Indirect immunofluorescence was  used  to determine if 
caveolin moved to  the  Golgi  apparatus  under  conditions 
where protein synthesis was inhibited (Fig. 4).  Cyclohexi- 
mide was added to cells 5 h before the experiment and kept 
present throughout the incubations.  Cells were either not 
treated (Fig. 4, A and B), incubated in the presence of cho- 
lesterol oxidase (Fig, 4, C and D), or exposed to cholesterol 
oxidase and then further incubated 1 h in the absence of the 
enzyme (Fig. 4, E  and F).  We then used immunofluores- 
cence to colocalize caveolin (Fig. 4, A,  C, and E) and the 
Golgi marker (3), galactosyltransferase (Fig. 4, B, D, and 
F). Normal surface membrane and Golgi apparatus staining 
was observed for the two markers in untreated cells (Fig. 4, 
A and B). After incubation in the presence of  cholesterol oxi- 
dase,  however, anti-caveolin IgG and anti-galactosyltrans- 
ferase IgG staining were superimposed, indicating that cav- 
colin had migrated to the Golgi apparatus (Fig. 4, C and D). 
Just as we observed with the electron microscope (Fig. 3), 
the Golgi apparatus appeared to be enlarged after cholesterol 
oxidation (compare Fig. 4, B with D). When the cholesterol 
oxidase was removed from the media and the cells incubated 
1 h, anti-caveolin IgG staining was normal (Fig. 4, E and F), 
which indicates that caveolin had returned to caveolae. There- 
fore,  cholesterol oxidase causes  caveolin to move to the 
Golgi apparatus but the same molecules can return once the 
enzyme is removed. 
The appearance of anti-caveolin IgG within the lumen of 
the Golgi cisternae after cholesterol oxidase treatment sug- 
gested that this integral membrane protein could move from 
the inside surface of the plasma membrane across the Golgi 
membrane. Therefore, we used two other standard methods 
to assess the topology of caveolin: antibody accessibility and 
protease protection. 
At the proper temperature and concentration, digitonin 
will permeabilize the plasma membrane but leave the ER and 
Golgi membranes intact (2). We used indirect immunofluo- 
rescence with an antibody against the resident ER protein 
BiP (immunoglobulin heavy chain binding protein, [4]) to 
determine the conditions for selective permeabilization of 
human fibroblasts (Fig. 5, D-F). We found that 15 #g/ml of 
digitonin did not allow the antibody access to the BiP (Fig. 
5 E) but treatment with 0.1%  Triton X-100 gave a typical 
anti-BiP IgG staining pattern (Fig. 5 D). We then incubated 
cells in the presence of cholesterol oxidase and sequentially 
treated them with  15 t~g/ml of digitonin and Triton X-100. 
These  cells  displayed  a  typical  anti-BiP  staining  pattern 
(compare Fig. 5, F with D). When untreated cells were per- 
meabilized with 15 #g/ml of digitonin and stained with anti- 
caveolin IgG, the staining pattern was normal (Fig. 5 A). By 
contrast, when we incubated the cells in the presence of cho- 
lesterol oxidase and then permeabilized them with digitonin, 
anti-caveolin IgG did not bind (Fig. 5 B). Antibody accessi- 
bility was restored after the cholesterol oxidase treated cells 
were sequentially treated with digitonin and Triton X-100 
(Fig. 5 C). 
Protease protection experiments also indicated that cave,  o- 
lin was crossing the ER-Golgi membrane system in choles- 
terol oxidase-treated cells (Fig. 6). Cells grown in cyclohexi- 
mide  to  prevent protein  synthesis  were  subjected  to  the 
different treatments and then gently homogenized in an iso- 
tonic  buffer to preserve the  integrity  of intracellular or- 
ganelles.  We added either 300 ftg/ml of trypsin or buffer 
alone directly to the homogenate and incubated the mixture 
for 30 min on ice.  The proteins were separated by elec- 
trophoresis and immunoblotted with anti-caveolin IgG (Fig. 
6).  Untreated cells that were not exposed to the protease 
showed a distinct caveolin band (Fig. 6, NT).  The addition 
of trypsin to untreated cell homogenates caused this band to 
disappear (Fig. 6, NT+T). Cholesterol oxidase-treated cells 
that  were  not  exposed  to  trypsin  also  had  a  single  im- 
munoreactive band  (Fig.  6,  CO). In contrast to untreated 
The Journal of Cell Biology, Volume  127, 1994  1190 Figure 4.  Reversible movement of caveolin to the Golgi apparatus  in response to cholesterol  oxidase.  Human fibroblasts  were incubated 
for 5 h in the presence of 50 tzg/ml of cycloheximide.  Ceils were then either not treated  (A and B), incubated  in the presence of 0.5 U/ml 
of cholesterol oxidase for 1 h at 37°C (C and D), or incubated  in the presence of cholesterol  oxidase followed by incubation in the absence 
of the enzyme for 1 h at 37°C (E and F).  Cycloheximide was present during all of the incubations.  At the end of the incubations,  the 
cells were fixed and processed to co-localize eaveolin (A, C, and E) and the Golgi apparatus  marker,  galactosyltransferase  (B, D, and F) 
by indirect immunofluorescence.  All ceils  were fixed with periodate-lysine-paraformaldehyde  fixative. Bar,  5.0 ~m. 
cells, this band was only slightly reduced in intensity when 
trypsin was added to the homogenate (Fig. 6, CO+T).  The 
protected  portion  of caveolin  was  degraded  when  Triton 
X-100  was  added  to  permeabilize  membranes  (Fig.  6, 
CO+T+Triton). Caveolin became completely protease sensi- 
tive  after  the  cholesterol  oxidase  was  removed  from  the 
medium and the cells  incubated an additional  1 h  (Fig.  6, 
R+T) even though protein  synthesis was inhibited. 
Low Temperatures and BFA Block Movement 
of Caveolin 
We next carried out a  series of experiments to identify the 
route that caveolin takes to get to the Golgi membrane. Since 
Golgi membrane and endosomal membrane traffic are both 
blocked at 18°C (8,  13), we incubated cells in the presence 
of cholesterol oxidase at this temperature and looked at the 
distribution of caveolin.  Immunofluorescence showed (Fig. 
Smart ¢t al. Caveolin Tragic to Golgi Region  1191 Figure 5. Effect of  cholesterol oxidase on accessibility of  caveolin to anti-caveolin IgG after digitonin permeabilization. Cells were incubated 
in the presence (B, C, E, and F) or absence (A and D) of cholesterol oxidase as described in Fig. 3. Cells stained with anti-BiP IgG (D-F) 
were permeabilized either with Triton X-100 (D), digitonin (E), or digitonin plus Triton X-100 (F). Cells stained with anti-caveolin IgG 
were permeabilized either with digitonin (A and B) or digitonin followed by Triton X-100 (C). All cells were fixed with periodate-lysine- 
paraformaldehyde fixative. Bar, 4.8 #m. 
7) that most of the caveolin remained associated with the cell 
surface (compare Fig.  7, A with B).  This temperature had 
no effect on the conversion of cholesterol to cholestenone 
(6%). When we shifted the  18°C-treated cells to 37°C  for 
30 min, almost all of the caveolin staining was in the Golgi 
apparatus (Fig. 7 C). 90 min after the shift, the caveolin was 
predominantly in vesicles near the cell center and in small 
vesicles distributed throughout the cell (Fig.  7 D). 
We also found that once caveolin had migrated to the Golgi 
region it would not return to the cell surface at 18°C (Fig. 
7). Caveolin was induced to move by treating the cells with 
cholesterol oxidase at 37°C.  The cells were washed to re- 
move the enzyme and further incubated 1 h at 18°C.  Fig. 7 
E shows that the caveolin remained in the Golgi region. Cel- 
lular cholestenone levels also remained constant during the 
incubation.  By contrast,  caveolin promptly returned to the 
cell surface when cells were incubated at 37°C for 1 h (Fig. 
7 F). 
We  took  advantage  of  the  18°C  block  and  used  im- 
munogold labeling to follow caveolin from the cell surface 
to the Golgi region after shifting the temperature to 37°C 
(Fig.  8). Incubating cells at 18°C in the absence of choles- 
terol oxidase had no eff-eet on the amount of anti-cave, olin 
specific immunogold in either the Golgi apparatus (Fig. 8 A) 
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oxidase  on trypsin sensitivity 
of  caveolin.  Human  fibro- 
blasts  that had been preincu- 
bated  in  the  presence  of 50 
#g/ml  of  cycloheximide  for 
5 h were incubated  either;  in 
the absence of  cholesterol oxidase (NT), in the presence of  0.5 U/ml 
of cholesterol oxidase (CO) for 1 h, or in the presence of choles- 
terol oxidase for I h followed by an additional  1 h in medium alone 
(R). Cells were homogenized as described in Materials  and Meth- 
ods and treated with 300/~g/ml of trypsin (NT +  T, CO +  T, R  + 
T, and CO +  T +  Triton) for 30 min on ice. One set ofhomogenates 
from cholesterol oxidase treated cells was mixed with 0.1% Triton 
X-100 (CO +  T +  Triton) to allow trypsin access to the sequestered 
protein. After each treatment,  the presence of caveolin was deter- 
mined by immunoblot as described in Materials  and Methods. 
or the ER compartments  (Fig.  8 B).  With cholesterol oxi- 
dase present at this temperature,  however, there was a  sub- 
stantial  amount of immunogold associated  with  the rough 
ER (Fig. 8 D  [*]) while the amount of gold label in the Golgi 
region remained unchanged (Fig. 8 C). Cells shifted to 37°C 
for 30 min had an increased amount of immunogold in the 
ER (Fig. 8 F) with a pronounced shift in distribution towards 
the smooth ER (Fig.  8 F  [*]).  Smooth ER could be recog- 
nized because often it was in continuity with the rough ER 
(Fig. 8, F and H; arrows) and the two ER compartments both 
contained a similar flocculent material in the lumen. Heavily 
labeled,  dilated smooth ER was also found associated with 
the Golgi apparatus  (Fig.  8 E  [*]).  After 90 min at 37°C, 
rough ER labeling declined (Fig. 8, G and H) but there was 
still good labeling of both smooth ER (Fig. 8 H) and Golgi- 
associated compartments  (Fig.  8  G). 
Figure 7. Effect of temperature on the distribution  of caveolin in cholesterol oxidase treated cells. Human fibroblasts were incubated under 
the following conditions: (A) no cholesterol oxidase at 18°C; (B) 0.5 U/ml cholesterol oxidase at 18°C; (C) cholesterol oxidase  at 18°C 
followed by cholesterol oxidase at 37°C for 30 min; (D) cholesterol  oxidase at 18°C followed by cholesterol oxidase at 37°C for 90 rain; 
(E) cholesterol oxidase at 37°C followed by medium alone at 18°C; (F) cholesterol  oxidase at 37°C followed by medium alone at 37°C. 
At the end of the incubations,  the cells  were fixed and processed to localize caveolin by indirect  immunofluorescence.  Bar,  5.7 #m. 
Smart et al. Caveolin Tmffw to Golgi Region  I l°B Figure 8. Immunogold localization  of  caveolin  during its migration to the Golgi region of  the cell in cholesterol oxidase treated cells. Human 
fibroblasts were either incubated in the presence (C and D ) or absence (A and B) of 0.5 U/mi of cholesterol oxidase at 18°C or they were 
incubated in the presence of cholesterol oxidase at 18°C and then warmed to 37°C in the presence of cholesterol oxidase for the indicated 
time (E-H). At the end of the incubations, cells were fixed and processed for immunogold localization  of caveolin as described. Representa- 
tive areas of the Golgi region (A, C, E, and G) and ER (B, D, F, and H) compartments are shown for each treatment. Bar, 0.4 pro. 
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results (Table I B). Incubation in the presence of cholesterol 
oxidase at 18°C alone caused a  12% decline in the amount 
of immunogold that was associated with caveolae. After the 
temperature was shifted to 37°C, there was a progressive loss 
of caveolin from caveolae until at 90 min 70% had migrated 
away from this compartment. The dispersed arrangement of 
the ER in fibroblasts made it impossible to determine quan- 
titatively if all of the caveolin had moved to the ER-Golgi 
compartment. 
These results suggest that the rough ER may be involved 
in the movement of caveolin to the Golgi region of the cell. 
If this is the pathway,  then brefeldin A  (BFA) should block 
the accumulation of caveolin in the Golgi area because this 
drug disrupts membrane traffic between ER and Golgi com- 
partments (20). Incubation of human fibroblasts in the pres- 
ence of BFA had no effect on the distribution of  caveolin (Fig. 
9  A).  When we switched these cells to medium that con- 
tained cholesterol oxidase and BFA (Fig. 9 B), anti-caveolin 
IgG labeling at the cell surface markedly declined. Instead, 
the staining pattern appeared as small, thin tubules that were 
diffusely distributed throughout the cell. When the BFA was 
removed in the presence of cholesterol oxidase, the caveolin 
migrated  to  the  Golgi  apparatus  (Fig.  9  C).  Caveolin 
returned to the cell surface after 1 h of incubation in the ab- 
sence of both BFA and cholesterol oxidase (Fig. 9 D). 
Discussion 
Previous immunogold localization studies showed that cav- 
eolin was a component of the spiral coat that decorates the 
inside surface of the plasma membrane (28).  The coat be- 
haves as if it is constructed from integral membrane proteins 
(28), and the amino acid sequence of caveolin predicts that 
it belongs to this class of molecules (10, 17). The migratory 
behavior of caveolin now suggests that it is not a structural 
molecule of caveolae because the morphology of caveolae 
appears normal after most of the caveolin moves to the Golgi 
region. Therefore, caveolae can apparently exist in the ab- 
sence of caveolin. This raises the possibility that there are 
tissue cells that have functional caveolae but no caveolin. 
Caveolin and Membrane Cholesterol 
The integrity of caveolae appears to depend on cholesterol 
(7). Previous electron microscopic studies have shown that 
caveolae are enriched in this sterol (33). We have also shown 
that depletion of intracellular cholesterol in  MA104  cells 
causes a 10-fold reduction in the number of invaginated cav- 
eolae (29) and a significant inhibition of potocytosis (7). In 
addition, treatment of cells with cholesterol-binding drugs 
such as filipin causes invaginated caveolae to become fiat 
(29).  These results suggested that potocytosis and,  conse- 
quently the opening and closing of the caveolae, are con- 
trolled by the lipid phase of the caveolar membrane. 
Cholesterol oxidase has long been used to distinguish be- 
tween plasma membrane and intraceUular cholesterol pools 
(19).  We can use the conversion of cholesterol to choleste- 
none by cholesterol oxidase to calculate that •6-7  % of the 
total cellular cholesterol is in caveolae. If90% of the choles- 
terol is in the plasma membrane (19) and caveolae occupy 
1-2 % of  this surface (30, 37), then caveolae membranes have 
Figure 9. BFA prevents cholesterol oxidase-induced migration of caveolin to the Golgi region of the cell. Human fibroblasts were subjected 
to the following treatments at 37°C: (A) 1 h in 18 #M (BFA) (B) 1 h pretreatment with BFA followed  by 1 h in 0.5 U/ml cholesterol oxidase 
plus BFA; (C) 1 h in BFA plus cholesterol oxidase followed by cholesterol oxidase alone for 1 h; (D) BFA plus cholesterol oxidase for 
1 h followed by 1 h in medium alone. At the end of the incubations, the cells were fixed and processed to localize caveolin by indirect 
immunofluorescence. Bar, 5.7 #m. 
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plasma membrane. 
Our results suggest that caveolin may play a role in main- 
taining the proper cholesterol environment in the caveolae. 
Upon oxidation of caveolar cholesterol the caveolin leaves 
the plasma membrane and moves to the Golgi region of the 
cell. Ordinarily caveolin is not seen in the Golgi region be- 
cause it spends most of the time on the cell surface. Oxida- 
tion of cholesterol perturbs  this balance  so  that caveolin 
spends more time in the Golgi apparatus, which allows de- 
tection by indirect immunofluorescence. The cholestenone 
remains in the caveolae but the caveolae regain the normal 
amount of cholesterol as the caveolin returns to the plasma 
membrane. The fate of the cholestenone is not known. In 
polarized  epithelial  cells  caveolin  associates  with  GPI- 
anchored proteins, glycolipids, and cholesterol in the Golgi 
apparatus (6, 21). The caveolin-lipid complex then moves to 
the cell surface in Golgi-derived transport vesicles (17). The 
cycling of caveolin between the plasma membrane and the 
Golgi apparatus may allow the cell to specifically control 
the level  of cholesterol in the caveolae and consequently 
their function. 
Caveolin is not the only protein that migrates to the Golgi 
apparatus in response to oxysterols. The cytoplasmic oxy- 
sterol-binding protein (OSBP)  also moves to the Golgi ap- 
paratus (27)  when complexed with 25-hydroxycholesterol. 
OSBP is normally diffuse in the cytoplasm but after cells are 
incubated in the presence of 25-hydroxycholesterol it be- 
comes associated with the Golgi apparatus. Our finding that 
caveolin moves to the Golgi apparatus suggests that the Golgi 
apparatus  may have a  general role to play in cholesterol 
homeostasis. 
Caveolin Can Move  from the Cell Surface 
to the Golgi  Apparatus 
The  most  remarkable  observation  in  this  study  was  the 
finding that caveolin, which is an integral membrane protein, 
can move to the Golgi apparatus region of the cell. The num- 
ber of caveolae on the surface of the cell changed very little 
after cholesterol oxidase treatment, which may mean that the 
caveolin is not moving to the Golgi apparatus in plasmalem- 
rnal vesicles that have formed from caveolae. We also were 
unable to detect caveolin in any type of transport vesicle. 
While there are other explanations for the observations we 
have presented, two of the experimental results suggest that 
the ER has some role to play in the movement of caveolin 
to the Golgi apparatus: (a) oxidation of cholesterol at 18°C 
caused immunogold-detectable caveolln to first appear as- 
sociated with the rough ER and this was followed by the 
progressive appearance of gold labeling in the Gelgi appara- 
tus after the cells were warmed to 370C for various times 
(Fig. 8); (b) brefeldin A, which inhibits membrane traffic be- 
tween the ER and Golgi apparatus (20), did not prevent the 
initial movement of caveolln into the cell but did prevent it 
from reaching the Golgi apparatus (Fig. 9).  Further work 
will be required to determine exactly how the endoplasmic 
reticulum participates in caveolin transport to the Golgi ap- 
paratus. 
The movement of caveolin to the Golgi region was revers- 
ible. Within one hour after cholesterol oxidase was removed 
from the medium, caveolin returned to the Triton X-100- 
insoluble fraction (Fig. 2) and to the cell surface (Fig. 4) 
even when protein synthesis was  blocked with cyclohexi- 
mide. This means that the same molecule of eaveolin can 
travel between these compartments in a  cycle. We do not 
know how caveolin returns to caveolae. 
The identification of a novel cycling system for caveolin 
that is revealed by the oxidation of caveolar cholesterol sup- 
ports previous findings that cholesterol is critical for the nor- 
mal function of this membrane specialization (7, 29).  The 
potential existence of a new pathway between the caveolae 
and the Golgi apparatus has broad implications for under- 
standing the function of normal and diseased cells. 
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